Delisting risk
Plus Therapeutics (PSTV)
Develops targeted radiotherapeutics and CNSide diagnostics for central nervous system cancers.
$3.87
At close−0.13 (−3.25%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Nov '24Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26
Reported−$0.37−$0.67−$0.56−$0.01−$0.04−$0.83−$1.05−$1.31
Estimate−$0.56−$0.51−$0.25−$0.09−$0.02−$0.80−$0.95−$0.88
Surprise+34.2%−31.4%−125.7%+88.9%−100.0%−4.2%−10.5%−48.9%
RevenueReportedEstimate
Nov '24Mar '25May '25Aug '25Oct '25Mar '26May '26Aug '26
Reported$1.5M$1.4M$1.1M$1.4M$1.4M$1.4M$1.0M$411.0K
Estimate$1.5M$1.5M$1.5M$1.5M$1.5M$1.2M$974.0K$1.1M
Surprise−0.7%−6.4%−28.6%−6.5%−6.5%+10.6%+5.5%−63.1%
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.88 | −$1.31 | −48.9% |
| May 2026 | −$0.95 | −$1.05 | −10.5% |
| Mar 2026 | −$0.80 | −$0.83 | −4.2% |
| Oct 2025 | −$0.02 | −$0.04 | −100.0% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.88 | −$1.31 | −48.9% | $1.1M | $411.0K | −63.1% | −0.5% |
| May 15, 2026 | −$0.95 | −$1.05 | −10.5% | $974.0K | $1.0M | +5.5% | +11.2% |
| Mar 12, 2026 | −$0.80 | −$0.83 | −4.2% | $1.2M | $1.4M | +10.6% | −15.2% |
| Oct 30, 2025 | −$0.02 | −$0.04 | −100.0% | $1.5M | $1.4M | −6.5% | +2.5% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 30, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Oct 31, 2023 | |||||||
| Aug 14, 2023 | |||||||
| Apr 20, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Oct 20, 2022 | |||||||
| Jul 21, 2022 | |||||||
| Apr 21, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Oct 21, 2021 | |||||||
| Jul 22, 2021 | |||||||
| Apr 22, 2021 | |||||||
| Feb 22, 2021 | |||||||
| Oct 22, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 15, 2019 | |||||||
| May 14, 2019 | |||||||
| Mar 29, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 23, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 3, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 | |||||||
| May 11, 2015 | |||||||